Filed Pursuant to Rule 424(b)(5)
Registration File No. 333-277167
PROSPECTUS SUPPLEMENT
(To Prospectus dated February 20, 2024)
$350,000,000

Common Shares of Beneficial Interest
We have entered into an equity distribution agreement with (i) each of Wells Fargo Securities, LLC, BNY Mellon Capital Markets, LLC, Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, KeyBanc Capital Markets Inc., TD Securities (USA) LLC and Truist Securities, Inc., each of which we refer to, when acting in their capacity as our sales agents, individually as a “Agent” and together as the “Agents,” and, if applicable, when acting in their capacity as agents for the Forward Purchasers (as defined below), individually as a “Forward Seller” and collectively as the “Forward Sellers,” and (ii) each of the Forward Purchasers (as defined below), relating to common shares of beneficial interest (“common shares”) offered by this prospectus supplement and the accompanying prospectus. In accordance with the terms of the equity distribution agreement, we may from time to time offer and sell common shares having an aggregate offering price of up to $350,000,000 through the Agents, each acting as our agent for the offer and sale of the shares of our common shares or to the Agents, each acting as principal, or through the Forward Sellers. Prior to entry into the equity distribution agreement, we terminated our prior at-the-market offering program. At the time of such termination, approximately $340 million remained unsold under such prior program.
Our common shares are traded on the New York Stock Exchange under the symbol “ELME”. The last reported sale price of our common shares on the New York Stock Exchange on February 16, 2024 was $14.11 per share.
Sales of common shares, if any, made through the Agents, acting as our sales agents, or the Forward Sellers, acting as agents for the applicable Forward Purchaser, or directly to an Agent, acting as principal, under this prospectus supplement and the accompanying prospectus may be made by any method permitted by law, including without limitation in transactions deemed to be an “at the market” offering as defined in Rule 415 under the Securities Act of 1933, as amended, sales made directly on the NYSE, on any other existing trading market for the Common Shares or to or through a market maker other than on an exchange. The Agents and the Forward Sellers will make all sales of the common shares (if acting as our sales agent) and of the borrowed common shares (if acting as agent for the relevant Forward Purchaser) on a best efforts basis using commercially reasonable efforts consistent with their normal trading and sales practices, on mutually agreed terms between the Agents and us or the Forward Sellers and us, as applicable.
The equity distribution agreement contemplates that, in addition to the issuance and sale of our common shares by us through the Agents (or to the Agents acting as principals), we may also enter into one or more forward sale agreements from time to time with each of Wells Fargo Bank, National Association, The Bank of New York Mellon, Citibank, N.A., Goldman Sachs & Co. LLC, KeyBanc Capital Markets Inc., The Toronto-Dominion Bank and Truist Bank or one of their respective affiliates. We refer to these entities, when acting in such capacity, individually as a “Forward Purchaser” and collectively as the “Forward Purchasers.” In connection with any forward sale agreement, the relevant Forward Purchaser (or its affiliate) will, at our request, use commercially reasonable efforts, consistent with its normal trading and sales practices and applicable law and regulations, to borrow from third parties and sell, through its affiliated Forward Seller, a number of our common shares equal to the number of common shares underlying the particular forward sale agreement to hedge such forward sale agreement. We will not initially receive any proceeds from any sales of our common shares by a Forward Seller in connection with a forward sale agreement.
Subject to certain conditions, we generally have the right to elect physical, cash or net share settlement under the forward sale agreements. We expect to fully physically settle each forward sale agreement, if any, with the relevant Forward Purchaser on one or more dates specified by us on or prior to the maturity date of such forward sale agreement. We may also elect to either cash settle or net share settle our obligations under the forward sale agreements if we determine that is in our best interest to do so. If we elect to cash settle any forward sale agreement, we may not receive any proceeds, and we may owe cash to the relevant Forward Purchaser. If we elect to net share settle any forward sale agreement, we will not receive any proceeds, and we may owe common shares to the relevant Forward Purchaser. See “Plan of Distribution—Sales Through Forward Sellers.”
Each Agent will receive from us a commission that will not exceed, but may be lower than, 2.0% of the gross sales price of all shares sold through it under the equity distribution agreement. Each Forward Seller will receive from us a commission at a mutually agreed rate in the form of a reduction to the initial forward sale price under the related forward sale agreement that will not exceed, but may be lower than, 2.0% of the gross sales price of the borrowed common shares sold by such Forward Seller during the applicable forward hedge selling period for such shares. In connection with the sale of the common shares on our behalf, each Agent and Forward Seller may be deemed to be an “underwriter” within the meaning of the Securities Act of 1933, as amended, and the compensation of the Agents and Forward Sellers may be deemed to be underwriting commissions or discounts.
Investing in our common shares involves risks. See “Risk Factors” beginning on page S-5 of this prospectus supplement, and in the reports we file with the Securities and Exchange Commission (the “SEC”) pursuant to the Securities Exchange Act of 1934, as amended (the “Exchange Act”), that are incorporated by reference in this prospectus supplement and the accompanying prospectus.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement and the prospectus to which it relates. Any representation to the contrary is a criminal offense.
| | | | | | |
Wells Fargo Securities | | BNY Mellon Capital Markets, LLC | | Citigroup | | Goldman Sachs & Co. LLC |
| | | | |
KeyBanc Capital Markets | | TD Securities | | Truist Securities |
The date of this prospectus supplement is February 20, 2024.